Results 1 to 10 of about 4,662,472 (212)

Overview of the role of liquid biopsy in cancer management

Translational Oncology, 2023
With the emergence of novel targeted therapeutic options in early-stage and advanced-stage malignancies, researchers have shifted their focus on developing personalized treatment plans through molecular profiling.
Tarek Assi, Rita Khoury, Rebecca Ibrahim, Maria Baz, Tony Ibrahim, Axel LE Cesne   +5 more
doaj   +1 more source

Expert consensus on diagnosis, treatment and fertility management of young breast cancer patients

Journal of the National Cancer Center, 2021
Breast cancer in young females is a relatively common disease in China. Young breast cancer has aggressive clinical and pathological features. During the treatment of young females with breast cancer, issues involving the choice of surgical methods ...
Committee of Diagnosis, Treatment, and Fertility Management of Chinese Young Breast Cancer Patients
doaj   +1 more source

Patient-Derived Cancer Models [PDF]

Cancers, 2020
For many decades, basic and preclinical cancer research has been based on the use of established, commercially available cell lines, originally derived from patients’ samples but adapted to grow indefinitely in artificial culture conditions, and on xenograft models developed by injection of these cells in immunocompromised animals [...]
Di Renzo M. F., Corso S.
openaire   +3 more sources

Development of a New Submaximal Walk Test to Predict Maximal Oxygen Consumption in Healthy Adults

Sensors, 2021
The aim of the study was to develop a simple submaximal walk test protocol and equation using heart rate (HR) response variables to predict maximal oxygen consumption (VO2max).
Hyuk In Yang, Wonhee Cho, Dong Hoon Lee, Sang-Hoon Suh, Justin Y. Jeon   +4 more
doaj   +1 more source

Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study

Frontiers in Medicine, 2021
Background: Investigational and marketed drugs for the treatment of multiple myeloma (MM) are associated with a range of characteristics and uncertainties regarding long term side-effects and efficacy.
Rosanne Janssens, Tamika Lang, Ana Vallejo, Jayne Galinsky, Ananda Plate, Kate Morgan, Elena Cabezudo, Raija Silvennoinen, Raija Silvennoinen, Daniel Coriu, Daniel Coriu, Sorina Badelita, Ruxandra Irimia, Ruxandra Irimia, Minna Anttonen, Riikka-Leena Manninen, Elise Schoefs, Martina Vandebroek, Anneleen Vanhellemont, Michel Delforge, Hilde Stevens, Steven Simoens, Isabelle Huys   +22 more
doaj   +1 more source

Physical Activity Level and Exercise Barriers According to the Transtheoretical Model in Breast Cancer Patients [PDF]

운동과학, 2022
Purpose The purpose of this study is to investigate the physical activity (PA) and exercise barriers of stages 0-3 breast cancer survivors according to the Transtheoretical Model (TTM).
Ha Nui Park, Su Jin Yeon, Ji Hee Min, Jeong Min Lee, Ansuk Jeong, Jee Ye Kim, Hyung Seok Park, Seung Il Kim, Justin Y. Jeon   +8 more
doaj   +1 more source

Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey

Orphanet Journal of Rare Diseases, 2021
Background Patients with rare cancers face challenges in the diagnostic and treatment phase, and in access to clinical expertise. Since studies on health care experiences of these patients in comparison to patients with more common cancers are scarce, we
Eline de Heus, Vivian Engelen, Irene Dingemans, Carol Richel, Marga Schrieks, Jan Maarten van der Zwan, Marc G. Besselink, Mark I. van Berge Henegouwen, Carla M. L. van Herpen, Saskia F. A. Duijts   +9 more
doaj   +1 more source

Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey

Frontiers in Endocrinology, 2020
Published studies on the risk of radiation-induced second primary malignancy (SPM) after radioiodine treatment (RAI) of differentiated thyroid cancer (DTC) refer mainly to patients treated as middle-aged or older adults and are not easily generalizable ...
Christoph Reiners, Rita Schneider, Tamara Platonova, Mikhail Fridman, Uwe Malzahn, Uwe Mäder, Alexis Vrachimis, Tatiana Bogdanova, Jolanta Krajewska, Rossella Elisei, Fernanda Vaisman, Jasna Mihailovic, Gracinda Costa, Valentina Drozd   +13 more
doaj   +1 more source

Cancer risks in thyroid cancer patients [PDF]

British Journal of Cancer, 1991
Cancer risks were studied in 834 thyroid cancer patients given 131I (4,551 MBq, average) and in 1,121 patients treated by other means in Sweden between 1950 and 1975. Record-linkage with the Swedish Cancer Register identified 99 new cancers more than 2 years after 131I therapy [standardised incidence ratio (SIR) = 1.43; 95% confidence interval (CI) 1 ...
P, Hall, L E, Holm, G, Lundell, G, Bjelkengren, L G, Larsson, S, Lindberg, J, Tennvall, H, Wicklund, J D, Boice   +8 more
openaire   +2 more sources

Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design

Trials, 2021
Background For patients with early breast cancer considered at very-low risk of local relapse, risks of radiotherapy may outweigh the benefits. Decisions regarding treatment omission can lead to patient uncertainty (decisional conflict), which may be ...
Indrani S. Bhattacharya, Joanne S. Haviland, Lesley Turner, Hilary Stobart, Ada Balasopoulou, Liba Stones, Anna M. Kirby, Cliona C. Kirwan, Charlotte E. Coles, Judith M. Bliss, on behalf of the PRIMETIME Trialists   +10 more
doaj   +1 more source